Navigation Links
US Microbiology Testing Market
Date:10/20/2011

NEW YORK, Oct. 20, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

US Microbiology Testing Market

http://www.reportlinker.com/p0591329/US-Microbiology-Testing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Highlights

  • Comprehensive 1,087-page analysis of the US microbiology testing market.
  • Major issues pertaining to the US microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
  • Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in US hospitals, blood banks, physician offices, public health and commercial laboratories.
  • Instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains 1,037 pages and 177 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests

1. AIDS

a. Background

Structure and Composition

Classification

Origin of AIDS

Animal Lentivirus Systems

Virus Receptos

HIV Infections in Humans

Pathogenesis & Pathology: Overview of

HIV Infection Course

CD4T Lymphocytes and Memory Cells

Monocytes and Macrophages

Lymphoid Organs

Neural Cells

Viral Coinfections

Clinical Findings

Plasma Viral Load

Pediatric AIDS

Neurologic Disease

Opportunistic Infections

Cancer

Immunity

Virus Isolation

Serology

Detection of Viral Nucleic

Acid and Antigens

Infectivity

Epidemiology

Worldwide Spread of AIDS

United States

Routes of Transmission

b. Diagnostic Tests

Laboratory Diagnosis

Enzyme Immunoassay Interpretation

Specific, Sensitivity, and Predictive

Value of Enzyme Immunoassays

Competition Assays

Western Blot Technique

ImmunoFluorescence Assay (IFA)

Radioimmunoprecipitation

HIV1/HIV2 Combination Testing

Methods of HIVAntigen Detection

Antigen Assays and Blood Screening

Urine Tests

Immunopathogenic Mechanism of HIV Infection

DNA Probes

Overview

Quantitative Polymerase Chain Reaction

In Situ PCR

Needed Improvements

Viral Load/Drug Resistance Testing

Genotype and Phenotype Testing

Blood Banking Consideration

c. Vaccines and Drugs

Antiviral Drugs

Vaccines Against HIV

Transmission of HIV in Blood Products

HIV Transmission in Transplant and

Artificial Insemination Recipients

2. Adenovirus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

d. AdenoAssociated Viruses(AAV)

3. Aeromonas

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

4. Anthrax/Bacillus Anthracis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

5. Arboviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

6. Babesiosis

a. Background

7. Bacillary Epithelioid Angiomatosis (BEA)

And Other Bartonella (Rochalimaea)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

8. Blastocystis Hominis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

9. Brucella

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

1. Campylobacter

a. Background

b. Diagnostic Tests

Identification from Culture

c. Vaccines and Drugs

11. Candida

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

12. Chagas Disease

a. Background

13. Chancroid

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

14. Chlamydia

a. Background

Chlamydia Psittaci

Chlamydia Pneumoniae

Chlamydia Trachomatis

b. Diagnostic Tests

c. Vaccines and Drugs

15. Clostridium Difficile

a. Background

Pediatric Infections

Epidemiology

b. Diagnostic Tests

Counterimmuno electrophoresis

Fluorescent Antibody Assays

Poloymerase Chain Reactions

c. Drugs and Vaccines

16. Coronaviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

17. Coxsackieviruses

a. Background

Herpangina

Handfootandmouth syndrome

Hepidemic Conjuctivitis

Pharingitis

Epidemic Pleurodynia

Myodarditis,Pericarditis

Overwhelming Infection of the Newborn

Acute Aseptic Meningitis

Undifferentiated Febrile Illness

Fever with upper respiratory infection

Encephalitis

Asymptomatic Infection

b. Diagnostic Tests

c. Vaccines and Drugs

18. CreutzfeldtJakob's Disease

a. Background

Blood Transmission

b. Diagnostic Tests

Major Commercial and Academic Players

Bayer

Disease Sciences/Bio Tec Global

Imperial College of Medicine

OrthoClinical Diagnostics

Pall

ProMetic Life Sciences

Proteome Sciences/Idexx

QOne Biotech

Serono

U.S. Agricultural Research Service

c. Vaccines

19. Cryptosporidium Parvum

a. Background

b. Diagnostic Tests

Histologic

Laboratory Parasitology

Serodiagnosis

c. Vaccines and Drugs

2. Cyclospora Cayetanensis

a. Background

Asymptomatic Infection

Diarrhea in Immunocompetent Persons

Diarrhea in Immunocompromisedersons

b. Diagnostic Tests

c. Vaccines and Drugs

21. Cytomegalovirus

a. Background

Chorioretinitis

Gastrointestinal

Central Nervous System Disease

b. Diagnostic Tests

c. Vaccines and Drugs

22. Ebola Virus

a. Background

Epidemiology

Hemorrhagic Fever

b. Diagnostic Tests

c. Vaccines and Drugs

23. E. Coli

a. Background

Role of Escherichia Coli in Causing Diarrhea

EPEC

ETEC

EIEC

EHEC

b. Diagnostic Tests

c. Vaccines and Drugs

24. EchoVirus

a. Background

Acute Aseptic Miningitisis

Encephalitis

Exanthems

Respiratory Disease

Myope;ricarditis

Neonatal Infections

b. Diagnostic Tests

c. Vaccines and Drugs

25. Encephalitis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

26. Enteroviruses

a. Background

b. Diagnostic Tests

Viral Isolation and Identification

Antibody Tests

c. Vaccines and Drugs

27. EpsteinBarr Virus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

28. Giardia Lamblia

a. Background

Life Cycle and Morphology

Morphology of Trophozoites

Clinical Disease

b. Diagnostic Tests

c. Vaccines and Drugs

29. Gonorrhea

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

3. Granuloma Inguinale

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

31. Hantavirus

a. Background

Identification of the Agent

Transmission

Other Rodent Hantaviruses

Distribution

Hantavirus Diseases

Epidemiology

Addendum in ProofNortheastern Connection

Previously Unknown Pathogens

Cases Nationwide

b. Diagnostic Tests

An Immunohistochemistry Approach

Hantavirus Rapid Diagnostic Test

ELISA Diagnosis of Hantavirus Pulmonary

Syndrome

IgG ELISA

IgM Capture ELISA

c. Vaccines and Drugs

32. Helicobacter Pylori

a. Background

Pathogenesis

Role in Peptic Ulcer Disease

Role in Gastric Cancer

Nonulcer Dyspepsia

b. Diagnostic Tests

c. Vaccines and Drugs

Specific Therapeutic Regimens

Who Should Be Treated?

Participants in Controlled Clinical Trials

Patients with Refractory Peptic Ulcer

Patients with Refractory NUD

Patients in HighRisk Groups for Gastric

Cancer

33. Hepatitis

a. Background

b. Hepatitis A

c. Hepatitis B

d. Hepatitis C

Classification

Transmission of Infection

Occupational Hazards

Acute Hepatitis

Diagnosis of Acute Infection

Chronic Hepatitis

HCV and Other Chronic Liver Diseases

Alcoholic Liver Disease

Hepatitis B Coinfection

Cirrhosis and Hepatocellular Carcinoma

Diagnostic Tests

Possible Indications for HCV RNA Testing

Conclusions and Future Direction

e. Hepatitis D

Historical Perspective

Epidemiology

HBVHDV "Coinfection" vs. "Superinfection"

Methods of Detecting HDV

Prevention

f. Hepatitis E

Background

Prevalence of the Disease

Diagnostic Tests

Epidemiologic Serosurveys

Serologic CrossReactivity

g. Hepatitis G

Vaccines and Drugs

34. Herpes Simplex Virus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

35. Human Herpes Virus6 (HHV6)

a. Background

HIV6 Infections

b. Diagnostic Tests

c. Vaccines and Drugs

36. Influenza Viruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

37. Legionella

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

38. Lyme Disease

a. Background

Clinical Description

Clinical Case Definition

Laboratory Criteria for Diagnosis

Case Classification

b. Diagnostic Tests

c. Vaccines and Drugs

39. Lymphogranuloma Venereum (LGV)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

4. Malaria

a. Background

b. Diagnostic Tests

Potential Diagnositic Problems with Positive Patients from Nonendemic Areas

Patient

Laboratory

Physician

c. Vaccines and Drugs

41. Measles (Rubeola)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

42. Meningitis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Development of Polysaccharide Vaccines

Quadrivalent Vaccine Development

Meningococcal A.C.Y. & W135 Vaccines

Efficacy of Group C Vaccine

Efficacy of Group A Vaccine

Combinations of Group A and C Vaccines

Group B Efficacy Trials

Future Direction

43. Microsporidium

a. Background

Prevalence and Geographic Distribution

Sources of Human Infection and Transmission

b. Diagnostic Tests

Light Microscopic Examination of Stool Specimens By Chromotrope Staining Stool Concentration Methods

Chemofluorescent Agents

Giemsa Staining of Stool Specimens

Cytologic Diagnosis

Histologic Examination

Electron Microscopy

Examination of Bodily Fluids

Examination of Tissue Sections

Immunofluorescence Detection Procedures

Serology

Cell Culture

Approach to Diagnosis

Evaluation of Patients with Presumptive

Intestinal Microsporidiosis

Evaluation of Patients with Presumptive

Ocular Microsporidiosis

c. Vaccines and Drugs

44. Mononucleosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

45. Mumps

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Efficacy of Vaccination

Future Issues

46. Mycoplasma

a. Background

Ureaplasma Urealyticum & Mycoplasma Hominis

b. Diagnostic Tests

c. Vaccines and Drugs

47. Papillomaviruses

a. Background

HPV in Cancer

Cervical Neoplasm

b. Diagnostic Tests

c. Vaccines and Drugs

Prevention

48. Parvovirus B19

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

49. Pneumonia

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

5. Polyomaviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

51. Pseudomonas Aeruginosa

a. Background

Virulence Factors

b. Diagnostic Tests

c. Vaccines and Drugs

52. Rabies

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

53. Respiratory Syncytial Virus (RSV)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

54. RhinoViruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

55. RotaVirus (REOVIRUS)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

56. Rubella(MEASLES)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Developing Countries

Elimination and Eradication of Measles

New Developments

57. Salmonellosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

58. Septicemia

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

59. Shigellosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

6. Staphylococcus Aureus

a. Background

The Genus Taphylococcus

b. Diagnostic Tests

c. Vaccines and Drugs

Prevention

61. Streptococci

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

Group A Streptococci

Group B Streptococci

62. Syphilis

a. Background

b. Diagnostic Tests

Biopsy

Rabbit Infectivity Testing

Other Diagnostic Modalities

c. Vaccines and Drugs

Syphilis and HIV Infection

Syphilis As a Cofactor for HIV Transmission

Basic Science Issues

63. Toxoplasmosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

64. Trichomonas Vaginalis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

65. Tuberculosis

a. Background

b. Diagnostic Tests

Microscopic Characteristics

Cultural Characteristics

Detection of Antibodies

Skin Tests

MDRTB

c. Vaccines and Drugs

66. Vibrio

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

67. West Nile Virus

a. Background

Clinical Syndromes

b. Diagnostic Tests

c. Vaccines and Drugs

68. Yersina

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

B. Instrumentation Review and Market Needs

Abbott AxSYM

Abbott IMx/IMx Select

Anagen AN2/AuraFlex

Beckman Coulter Access

BioChem Pharma/SR1

BioMerieux/Vitek Vidas

Biotrol System 7

Chiron ACS: Centaur

Chiron ACS: 18

J&J Diagnostics/Amersham Amerlite

J&J Diagnostics Vitros ECi

Olympus PK31

Roche Cobas Core

Roche Elecsys 11/21

Roche ES 22

Roche ES 33

Roche ES 3/3AL

Siemens ELISA Processor II/III

Siemens Immuno 1

Siemens/Opus/Plus/Magnum

Siemens Stratus

Tosoh AIA12/12DX/NexIA/6

Wallac/Pharmacia Delfia

C. Emerging Diagnostic Technologies

1. DNA Probes

a. Technology Overview

b. Amplification Methods

Polymerase Chain Reaction

Robotics

Temperature Cyclers

PCR Variations

ImmunoPCR

QCPCR

DAPPCR

Ligase Chain Reaction

Branched DNA

QBeta Replicase

NucleicAcid SequenceBased

Strand Displacement Activation

SelfSustained Sequence Replicase

2. Monoclonal Antibodies

3. Immunoassays

a. Technological Principle

b. Enzyme Immunoassays (EIA)

Overview

ELISA

Dot Immunobinding Assays

Capillary Immunoassays

ParticleMembrane Capture

Immunoassays

Enzyme Amplification

c. Fluorescent Immunoassays

Fluorescence Polarization

TimeResolved Pulse Fluorescence

d. Luminescence

Chemiluminescence

Bioluminescence

e. Latex Agglutination

f. Immunoprecipitation

4. Differential Light Scattering

5. Microcomputers and Automation

6. Artificial Intelligence

7. Liposomes

8. Flow Cytometry

9. Chromatography

1. MRI

11. Gel Microdroplets

12. Other

D. Personal Testing

E. Worldwide Business Environment

F. Worldwide Market Structure

G. Worldwide Market Size and Growth

U.S.A.

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Reimbursement

4. Industry Consolidation

5. Managed Care

a. HMO

b. PPO

6. Hospitals

7. Admissions

8. Length of Stay

9. Industry Diversification

1. Physician Demographics

11. Population Aging

a. Chronic Illness

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

12. Laboratory Regulations

13. FDA Reform

C. Market Structure

1. Centralized Testing

a. Hospitals

b. Commercial/Private Laboratories

c. Blood Banks

1) Community and Regional Centers

2) Plasma Fractionation Centers

2. Decentralized Testing

a. Physician Offices/Group Practices

b. Point of Care Testing

c. Other Decentralized Testing Locations

D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

A. Instrumentation

B. Reagent Kits and Test Systems/Panels

C. Computers, Software and Automation

D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized

Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation

Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Assessments

Abbott

Affymetrix

Beckman Coulter

Becton Dickinson

bioMerieux

BioRad

Cepheid

Diamedix

DiaSorin

Eiken Chemical

Enzo Biochem

Fujirebio

GenProbe

Hologic

ID Biomedical

J&J Diagnostics

Kreatech

Life Technology

Lonza

Nanogen

Novartis Diagnostics

Qiagen

Roche

Scienion

Sequenom

SeraCare

Siemens

Takara Bio

Thermo Fisher

Wallac

Wako

List of Tables

Major Companies Developing or Marketing AIDS Tests

Major Companies Developing or Marketing Adenovirus Tests

Major Companies Developing or Marketing Bartonella Tests

Major Companies Developing or Marketing

Campylobacter Tests

Major Companies Developing or Marketing Candida Tests

Major Companies Developing or Marketing Chlamydia Tests

Major Companies Developing or Marketing Clostridium Tests

Major Companies Developing or Marketing Coronavirus Tests

Major Companies Developing or Marketing Cryptosporidium Tests

Major Companies Developing or Marketing CMV Tests

Major Companies Developing or Marketing Echovirus Tests

Major Companies Developing or Marketing Enterovirus Tests

Major Companies Developing or Marketing EBV Tests

Major Companies Developing or Marketing Giardia Tests

Major Companies Developing or Marketing Gonorrhea Tests

Major Companies Developing or Marketing Hantavirus Tests

Major Companies Developing or Marketing Helicobacter Pylori Tests

Major Companies Developing or Marketing Hepatitis Tests

Major Companies Developing or Marketing Herpes Tests

Major Companies Developing or Marketing Influenza Tests

Major Companies Developing or Marketing Legionella Tests

Major Companies Developing or Marketing Lyme Disease Tests

Major Companies Developing or Marketing Lymphogranuloma Tests

Major Companies Developing or Marketing Malaria Tests

Major Companies Developing or Marketing Measles Tests

Major Companies Developing or Marketing Meningitis Tests

Major Companies Developing or Marketing Microsporidium Tests

Major Companies Developing or Marketing Mononucleosis Tests

Major Companies Developing or Marketing Mumps Tests

Major Companies Developing or Marketing Mycoplasma Tests

Major Companies Developing or Marketing Papilloma Virus Tests

Major Companies Developing or Marketing Parvovirus Tests

Major Companies Developing or Marketing Pneumonia Tests

Major Companies Developing or Marketing RSV Tests

Major Companies Developing or Marketing Rotavirus Tests

Major Companies Developing or Marketing Rubella Tests

Major Companies Developing or Marketing Salmonella Tests

Major Companies Developing or Marketing Septicemia Tests

Major Companies Developing or Marketing Shigella Tests

Major Companies Developing or Marketing Staphylococci Tests

Major Companies Developing or Marketing Streptococci Tests

Major Companies Developing or Marketing Syphilis Tests

Major Companies Developing or Marketing Toxoplasmosis Tests

Major Companies Developing or Marketing Trichomonas Tests

Major Companies Developing or Marketing Tuberculosis Tests

Major Companies Developing or Marketing West Nile Tests

Major Companies Developing or Marketing Yersinia Tests

Worldwide All Market Segments Laboratories Performing Microbiology Tests by Country

Worldwide All Market Segments Total Microbiology Test Volume Forecast by Country

Worldwide All Market Segments Total Microbiology Diagnostics Market Forecast by Country

Infectious Disease Tests Major Issues and Market

Potential For Personal Testing

U.S.A. Summary Table

All Infectious Diseases Test Volume and Diagnostics

Sales Forecast by Market Segment

U.S.A.

Laboratories Performing Infectious Disease Tests by Market Segment

U.S.A.

Hospital Laboratories Performing Infectious Disease Tests by Bed Size

U.S.A.

Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume

U.S.A.

Physician Office Laboratories Performing Infectious Disease Tests by Practice Size

U.S.A.

All Market Segments Infectious Disease Test Volume Forecast

U.S.A.

Hospital Laboratories Infectious Disease Test Volume Forecast

U.S.A.

Blood Banks Infectious Disease Test Volume Forecast

U.S.A.

Physician Office Laboratories Infectious Disease Test Volume Forecast

U.S.A.

Commercial/Private Laboratories Infectious Disease Test Volume Forecast

U.S.A.

Public Health Laboratories Infectious Disease Test Volume Forecast

U.S.A.

All Market Segments Infectious Disease Diagnostics Market Forecast

U.S.A.

Hospital Laboratories Infectious Disease Diagnostics Market Forecast

U.S.A.

Blood Banks Infectious Disease Diagnostics Market Forecast

U.S.A.

Physician Office Laboratories Infectious Disease Diagnostics Market Forecast

U.S.A.

Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast

U.S.A.

Public Health Laboratories Infectious Disease Diagnostics Market Forecast

U.S.A.

HIV or HIVI/HIVII Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

BEA Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Candida Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

CMV Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

EBV Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Giardia Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

AntiHBC Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

AntiHBS Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

AntiHAV Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Influenza Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Legionella Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Malaria Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Measles Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Mumps Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment

U.s.a.

Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Rabies

Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

RSV

Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Rubella Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Shigella Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

West Nile Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

AIDS Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Adenovirus Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Campylobacter Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Candida Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Chancroid Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Chlamydia Testing Market Diagnostics Sales by Major Supplier

U.S.A.

CMV Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Cryptosporidium Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Echovirus Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Enterovirus Testing Market Diagnostics Sales by

Major Supplier

U.S.A.

EBV Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Giardia Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Gonorrhea Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Hepatitis Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Hepatitis C Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Herpes Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Influenza Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Legionella Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Lyme Disease Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Measles Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Meningitis Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Mononucleosis Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Mumps Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Mycoplasma Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Pneumonia Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Rabies Testing Market Diagnostics Sales by Major Supplier

U.S.A.

RSV Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Rotavirus Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Rubella Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Salmonella Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Septicemia Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Shigella Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Streptococci Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Syphilis Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier

To order this report:

: US Microbiology Testing Market

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related biology technology :

1. Tips from the journals of the American Society for Microbiology
2. Tips from the journals of the American Society for Microbiology
3. Laboratory Customers Name bioMerieux Top Of Class for Microbiology
4. Tips from the journals of the American Society for Microbiology
5. Cepheid Announces Symposium Speakers and Program Highlights for 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
6. NanoLogix Inc. to Exhibit at The American Society for Microbiology (ASM) General Meeting in Philadelphia; Announces Two New Patents
7. Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
8. TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products
9. Shimadzu and bioMerieux Enter into Partnership for Mass Spectrometry Applications in Microbiology
10. BD Expands Industrial Microbiology Rapid Methods Portfolio
11. Magellan Biosciences and Miacom Diagnostics Team Up to Enable Faster, Easier Identification of Pathogens as Part of Magellans End-to-End Suite of Microbiology Products Designed to Streamline Lab Workflow and Enable Better Treatment Decisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):